Niagen Bioscience Inc (NAGE) Financials

NAGE Assets vs Liabilities
DateAssetsLiabilities
March 31, 2026 114.3 million 32.0 million
Dec. 31, 2025 106.4 million 29.9 million
Sept. 30, 2025 98.1 million 27.5 million
June 30, 2025 91.5 million 27.3 million

NAGE Free Cash Flow and Stock based compensation
Graph available only for paid members. Upgrade to see it.
DateFree Cash FlowStock based compensation
March 31, 2026 -1.3 million ?
Dec. 31, 2025 523000 1.7 million
Sept. 30, 2025 3.7 million 1.8 million
June 30, 2025 1.1 million 1.5 million

NAGE Net Income

No data available :(

NAGE Cash and Debt
Graph available only for paid members. Upgrade to see it.
DateCashDebtCapital Lease
March 31, 2026 66.5 million - 1.5 million
Dec. 31, 2025 64.8 million - 1.8 million
Sept. 30, 2025 64.1 million - 3.1 million
June 30, 2025 60.3 million - 3.3 million

NAGE Shares Outstanding
Graph available only for paid members. Upgrade to see it.
DateShares Outstanding
March 31, 2026 84.6 million
Dec. 31, 2025 84.4 million
Sept. 30, 2025 86.6 million
June 30, 2025 86.2 million

NAGE Expenses
Graph available only for paid members. Upgrade to see it.
DateCapexR&DG&AS&M
March 31, 2026 61000 1.5 million 16.9 million -
Dec. 31, 2025 101000 1.7 million 17.9 million -
Sept. 30, 2025 24000 1.8 million 15.9 million 8.8 million
June 30, 2025 135000 1.6 million 15.5 million 8.2 million

NAGE Cost of Revenue
Graph available only for paid members. Upgrade to see it.
DateRevenueCost of Revenue
March 31, 2026 31.5 million 11.5 million
Dec. 31, 2025 33.8 million 12.1 million
Sept. 30, 2025 34.0 million 12.1 million
June 30, 2025 31.1 million 10.9 million

NAGE

Price: $3.43

52 week price:
3.37
14.69

Earnings Per Share: 0.21 USD

P/E Ratio: 18.95

Exchange: NCM

Sector: Healthcare

Industry: Biotechnology

Market Capitalization: 274.8 million

Links: